Quantcast
Last updated on April 16, 2014 at 11:02 EDT

Chinese Orthopedic Biomaterials Market

September 25, 2013

Reportbuyer.com just published a new market research report: Chinese Orthopedic Biomaterials Market.

London (PRWEB) September 25, 2013

The Chinese orthopedic biomaterials market is expected to approach $522.3 million by 2019.

The bone graft substitute segment is expected to constitute the majority of the Chinese orthopedic biomaterials market.

The Chinese orthopedic biomaterials market comprises bone graft substitutes which is segmented into allografts, demineralized bone matrices (DBM) and synthetics, and hyaluronic acid (HA) viscosupplementation. The market has seen increased interest in domestic competitors and some domestic competitors are in the process of clinical trials for synthetic, DBM, and bone morphogenetic protein (BMP) products. Further growth in the overall market will be fuelled by the Chinese government improving healthcare coverage across the country, leading to an increase in the number of Chinese people with more disposable income. The previous drivers are magnified by the increasing population of elderly, and the increased acceptance of surgery as a solution.

Scope:

This report pertains to a forecast period of 10 years (2009 – 2019) for China.

Report Contents:

Competitor Analysis

Identified Strategic Opportunities

Market Overview by Segment & Country

Trend Analysis by Segment & Country

Market Drivers & Limiters

Mergers & Acquisitions

Customer Feedback and Market Monitoring

Main Markets Included:

Bone Graft Substitute

Hyaluronic Acid Viscosupplementation

Sub-Segments Included:

Synthetic Allograft

Demineralized Bone Matrix

Cervical Spine

Thoracolumbar Spine

Trauma & Reconstruction

Craniomaxillofacial

Single-injection products

Three-injection cycle products

Five-injection cycle products

Companies Included:

Wright Medical

Bloomage Freda Biopharm

Shanghai Haohai Biological

Kunming Baker Norton

Shanghai Baijiayi

Xin Kang Cheng

Shanxi Aurui

Biolu

Hubei Lianjie

Shanghai Anjiu

Biocomposites

DePuy Synthes NovaBone

Rebone

Others Include:

Award Trade Corporation (Kunming), Beijing Fito Medical, Beijing St. Jane Medical, Liweize Medical Devices, Shanghai Medcare, Shenzhen SMARL, and various domestic companies.

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

TABLE OF CONTENTS I

LIST OF FIGURES IV

LIST OF CHARTS VI

EXECUTIVE SUMMARY 1

1.1 CHINESE MARKET FOR ORTHOPEDIC BIOMATERIALS 1

1.2 GROWTH TRENDS BY SEGMENT 1

1.3 PROCEDURES 1

1.4 BONE GRAFT SUBSTITUTE MARKET 1

1.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 1

1.6 COMPETITIVE ANALYSIS 1

RESEARCH METHODOLOGY 2

2.1 RESEARCH SCOPE 2

2.2 IDATA’S 9-STEP METHODOLOGY 2

Step 1: Project Initiation & Team Selection 3

Step 2: Prepare Data Systems and Perform Secondary Research 5

Step 3: Preparation for Interviews & Questionnaire Design 6

Step 4: Performing Primary Research 7

Step 5: Research Analysis: Establishing Baseline Estimates 9

Step 6: Market Forecast and Analysis 10

Step 7: Identify Strategic Opportunities 12

Step 8: Final Review and Market Release 13

Step 9: Customer Feedback and Market Monitoring 13

CHINESE ORTHOPEDIC BIOMATERIALS MARKET 14

3.1 INTRODUCTION 14

3.1.1 Growth Factors 15

3.1.2 Bone Graft Substitutes 15

3.1.3 Hyaluronic Acid Viscosupplementation 15

3.2 CURRENCY EXCHANGE RATE 16

3.3 PROCEDURES 17

3.3.1 Total Orthopedic Bone Graft Substitute Procedures by Indication 17

3.3.2 Total Orthopedic Bone Graft Substitute Procedures by Segment 21

3.3.3 Bone Graft Substitute Procedures 25

3.3.4 Hyaluronic Acid Viscosupplementation Procedures 26

3.4MARKET OVERVIEW 27

3.5 TREND ANALYSIS 32

3.6MARKET DRIVERS AND LIMITERS 33

3.6.1 Market Drivers 33

3.6.2 Market Limiters 33

3.7 COMPETITIVE ANALYSIS 35

3.7.1 Leading Competitors 35

3.7.2 Market Concentration 36

3.8MERGERS AND ACQUISITIONS 38

BONE GRAFT SUBSTITUTE MARKET 39

4.1 INTRODUCTION 39

4.1.1.1 Autograft 40

4.1.1.2 Non-Proprietary Allograft 40

4.1.1.3 Demineralized Bone Matrix 40

4.1.1.4 Synthetic 41

4.1.2 Volumes Represented per Procedure 42

4.2MARKET OVERVIEW 43

4.3MARKET ANALYSIS & FORECAST 45

4.3.1 Allograft Market 49

4.3.1.1 Total Allograft Market 49

4.3.2 Synthetic Market 52

4.3.2.1 Total Synthetic Market 52

4.3.3 Demineralized Bone Matrix Market 54

4.3.3.1 Total DBM Market 54

4.3.4 Market by Indication 56

4.3.5 Cervical Market 59

4.3.6 Thoracolumbar Market 62

4.3.7 Trauma & Reconstruction Market 65

4.3.8 Craniomaxillofacial Market 68

4.3.8.1 Craniomaxillofacial Market 68

4.4 DRIVERS AND LIMITERS 71

4.4.1 Market Drivers 71

4.4.2 Market Limiters 71

4.5 COMPETITIVE ANALYSIS 73

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 75

5.1 INTRODUCTION 75

5.1.1.1 Single-Injection Products 76

5.1.1.2 Three-Injection Cycle Products 76

5.1.1.3 Five-Injection Cycle Products 76

5.2MARKET OVERVIEW 77

5.3MARKET ANALYSIS & FORECAST 79

5.3.1 Single Injection Market 83

5.3.2 Three Injection Cycle Market 86

5.3.3 Five Injection Cycle Market 88

5.4 DRIVERS AND LIMITERS 90

5.4.1 Market Drivers 90

5.4.2 Market Limiters 90

5.5 COMPETITIVE ANALYSIS 92

APPENDIX: (OPTIONAL) 94

ABBREVIATIONS 95

Read the full report:

Chinese Orthopedic Biomaterials Market

http://www.reportbuyer.com/pharma_healthcare/biotechnology/chinese_orthopedic_biomaterials_market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biomaterial

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/9/prweb11160533.htm


Source: prweb